Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Business & Industry
- AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
- Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
- New scholarships worth EUR 417,000 awarded by Bayer Foundation to promote international talents
- Pfizer goes to Court to allow competition for biologics and expand options for patients
- IPF World Week 2017: Boehringer Ingelheim helps healthcare professionals to 'listen for the sounds of IPF'
Research & Development
- Danish discovery can pave the way for more effective cholesterol medicine
- Scientists find way to convert bad body fat into good fat
- Beta blockers not needed after heart attack if other medications taken
- Cells programmed like computers to fight disease
- 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
- Type 2 diabetes is a reversible condition
- Protein research could help in hunt for Alzheimer's and Parkinson's cures
Conferences & Events
- SMi presents Europe's leading 10th annual conference and exhibition: Pre-Filled Syringes Europe 2018
- Ophthalmic Drugs Conference 2017
- Lyophilization USA Conference 2017
- IT Transformation and Cloud Content Management for MedTech, Biotechnology and Pharmaceutical Companies
- The future has arrived #CUBETechFair
- eyeforpharma Philadelphia 2017: Be the trusted healthcare partner #efpPhilly
- DIA EuroMeeting explores the road ahead for drug development in the EU and UK
Regulatory Affairs
- FDA approves first biosimilar for the treatment of cancer
- FDA approves Mylotarg for treatment of acute myeloid leukemia
- FDA approval brings first gene therapy to the United States
- FDA approves first U.S. treatment for Chagas disease
- FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
- FDA to expand public education campaign to focus on prevention of youth e-cigarette use
- FDA approves treatment for chronic graft versus host disease